KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Steris (STE) EBT (2018 - 2025)

Steris has reported EBT over the past 8 years, most recently at $257.8 million for Q4 2025.

  • For Q4 2025, EBT rose 12.72% year-over-year to $257.8 million; the TTM value through Dec 2025 reached $940.1 million, up 19.1%, while the annual FY2025 figure was $796.2 million, 13.29% up from the prior year.
  • EBT for Q4 2025 was $257.8 million at Steris, up from $253.1 million in the prior quarter.
  • Over five years, EBT peaked at $257.8 million in Q4 2025 and troughed at -$29.0 million in Q2 2021.
  • A 5-year average of $171.2 million and a median of $178.8 million in 2021 define the central range for EBT.
  • Biggest five-year swings in EBT: tumbled 126.68% in 2021 and later soared 603.85% in 2022.
  • Year by year, EBT stood at $182.4 million in 2021, then fell by 5.96% to $171.5 million in 2022, then rose by 10.53% to $189.6 million in 2023, then grew by 20.62% to $228.7 million in 2024, then rose by 12.72% to $257.8 million in 2025.
  • Business Quant data shows EBT for STE at $257.8 million in Q4 2025, $253.1 million in Q3 2025, and $231.9 million in Q2 2025.